Real-World Clinical Effectiveness and Cost Savings of Liraglutide Versus Sitagliptin in Treating Type 2 Diabetes for 1 and 2 Years
Crossref DOI link: https://doi.org/10.1007/s13300-018-0432-2
Published Online: 2018-05-09
Published Print: 2018-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Li, Qian http://orcid.org/0000-0002-3785-796X
Ganguly, Rahul
Ganz, Michael L.
Gamble, Cory
Dang-Tan, Tam
Funding for this research was provided by:
Novo Nordisk Inc
Article History
Received: 23 February 2018
First Online: 9 May 2018